Global Oncology Partnering 2017-2022: Featuring Key Players AG Mednet, 3B Pharmaceuticals, Abbisko Therapeutics and Others
June 29, 2022 07:58 ET
|
Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2017-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Curium Announces the Submission of its Marketing Authorization Application for [18F]-DCFPyL to the European Medicines Agency
June 27, 2022 01:00 ET
|
Curium
Submission follows the completion of Phase III PYTHON clinical trial of [18F]-DCFPyL for recurrent prostate cancer in Europe in May 2022Phase III PYTHON clinical trial results to be presented at the...
Nuclear Medicine Market Size Worth USD 13 Billion by 2027 at 13% CAGR - Report by Market Research Future (MRFR)
June 20, 2022 08:08 ET
|
Market Research Future
New York, USA, June 20, 2022 (GLOBE NEWSWIRE) -- Nuclear Medicine Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Nuclear Medicine Market...
Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial
May 12, 2022 01:05 ET
|
Curium
ST. LOUIS, May 12, 2022 (GLOBE NEWSWIRE) -- Curium confirmed today no supply challenges of 177Lu-PSMA-I&T for the Phase 3 ECLIPSE clinical trial (NCT05204927), evaluating Lutetium...
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
May 03, 2022 01:05 ET
|
Curium
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) -- Curium announced today it has successfully enrolled and dosed patients in the ECLIPSE Trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized...
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
April 19, 2022 01:00 ET
|
Curium
ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market. Curium will now...
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
April 05, 2022 01:05 ET
|
Curium
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug...
Terrestrial Energy and ANSTO Sign Agreement for Used IMSR Fuel Management
February 02, 2022 08:29 ET
|
Terrestrial Energy Inc.
SYDNEY, Australia and OAKVILLE, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ANSTO, Australia’s knowledge centre for nuclear science and technology, and Terrestrial Energy have agreed to explore ANSTO...
Global Radiopharmaceuticals Market Analysis Report 2021: Market to Reach $8.9 Billion by 2026 - COVID-19 Presents Generational Opportunity
January 27, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
January 25, 2022 01:29 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company...